Mb Pharma S.r.o.

Mb Pharma S.r.o. is a company in Prague, Czech Republic that has taken part in 2 EU-funded projects since 2024, receiving €275k in EU funding.

EU funding received€275k
EU projects2
As coordinator0
Running now2
First EU project2024
Latest project2024
CountryCzech Republic
EU registration (PIC)897113231
On this page · 4 sections→

Where the EU money came from

Funding by EU programme. Amounts are Mb Pharma S.r.o.'s own share of each project, not the project's full budget.

  • European Defence Fund (EDF)€275k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • RESILIENCE-R-2023Partner

    First research action for Medical counter measures performed in the frame of the RESILIENCE FPA consortium

    European Defence Fund (EDF) · 2024–2027 · Project on the EU portal ↗

    €275ktheir share
  • RESILIENCEPartner

    European Strategic alliance for research, development and innovation on medical countermeasures against CBRN threats

    European Defence Fund (EDF) · 2024–2027 · Project on the EU portal ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime